Geir Olav Melingen has been appointed Chief Executive Officer of Benchmark Genetics, the company announced this week.
Melingen brings extensive experience in aquaculture genetics and animal health, having served in several senior roles at Benchmark Holdings since 2019, including Head of Salmon Health and Genetics and Head of Benchmark Genetics. He previously held senior positions at SalMar Genetics and Fish Vet Group, and was CEO of Bergen Aquarium from 2015 to 2019.
Novo Holdings completes £260m acquisition of Benchmark Genetics
Benchmark Genetics operates breeding programmes for salmon and shrimp, with facilities in Norway, Iceland, Chile, the US and Colombia.
Melingen holds a doctorate in fish immunology and physiology from the University of Bergen.